Apotex Launches Generic Norvasc
This article was originally published in The Pink Sheet Daily
Executive Summary
Launch undercuts Mylan’s claimed 180-day exclusivity for amlodipine.
You may also be interested in...
Plavix Patent Upheld By Court, Blocking Generic Clopidogrel
Apotex says it will immediately appeal the decision in favor of Sanofi-Aventis/Bristol-Myers Squibb.
Plavix Patent Upheld By Court, Blocking Generic Clopidogrel
Apotex says it will immediately appeal the decision in favor of Sanofi-Aventis/Bristol-Myers Squibb.
Norvasc Generic Substitution Rate Reaches Nearly 77 Percent
Rate has increased nearly five fold since amlodipine generics hit the market.